Abstract:In transcatheter aortic valve replacement (TAVR) recipients, the optimal management of concomitant chronic obstructive coronary artery disease (CAD) remains unknown. Some advocate for pre-TAVR percutaneous coronary intervention, while others manage it expectantly. The aim of this study was to assess the impact of varying degrees and extent of untreated chronic obstructive CAD on TAVR and longer-term outcomes. The authors conducted a retrospective cohort study of TAVR recipients from January 2015 to November 2021, separating patients into stable non-obstructive or varying degrees of obstructive CAD. The major outcomes of interest were procedural all-cause mortality and complications, major adverse cardiovascular events, and post-TAVR unplanned coronary revascularization. Of the 1911 patients meeting inclusion, 75%, 6%, 10%, and 9% had non-obstructive, intermediate-risk, high-risk, and extreme-risk CAD, respectively. Procedural complication rates overall were low (death 0.4%, shock 0.1%, extracorporeal membrane oxygenation 0.1%), with no difference across groups. At a median follow-up of 21 months, rates of acute coronary syndrome and unplanned coronary revascularization were 0.7% and 0.5%, respectively, in the non-obstructive population, rising in incidence with increasing severity of CAD ( P < .001 for acute coronary syndrome/unplanned coronary revascularization). Multivariable analysis did not yield a significantly greater risk of all-cause mortality or major adverse cardiovascular events across groups. One-year acute coronary syndrome and unplanned coronary revascularization rates in time-to-event analyses were significantly greater in the non-obstructive (98%) vs. obstructive (94%) subsets ( P log-rank < .001). Transcatheter aortic valve replacement can be performed safely in patients with untreated chronic obstructive CAD, without portending higher procedural complication rates and with relatively low rates of unplanned coronary revascularization and acute coronary syndrome at 1 year. ( A ) Definitions for the four categories of coronary artery disease (CAD) studied alongside the breakdown of transcatheter aortic valve replacement (TAVR) valve type with 91% balloon-expandable valves (BEV) and 9% self-expanding valves (SEV). Procedural complication rates were minimal across the 1911 patients studied. ( B ) Cumulative incidence curve of major adverse cardiovascular events (MACE) [acute coronary syndrome (ACS), stroke, or heart failure hospitalizations] demonstrating no significant difference between obstructive and non-obstructive groups ( P = .609) ( C ) Cumulative incidence curve of unplanned coronary revascularization showing a significant difference between obstructive and non-obstructive groups ( P = .006). ( D ) Multivariable analyses for all-cause mortality and MACE. CI, confidence interval; ECMO, extracorporeal membrane oxygenation; HR, hazard ratio; LAD, left anterior descending artery; LCX, left circumflex artery; LM, left main; N/A, not available; RCA, right coronary artery.

Aortic Stenosis With Coronary Artery Disease: SAVR or TAVR-When and How?

Surgical versus Interventional Treatment of Concomitant Aortic Valve Stenosis and Coronary Artery Disease

Percutaneous versus surgical approach to aortic valve replacement with coronary revascularization: A systematic review andmeta-analysis

Coronary artery disease and TAVI: Current evidence on a recurrent issue

Complete transcatheter versus surgical approach to aortic stenosis with coronary artery disease: A systematic review and meta-analysis

Complete transcatheter versus complete surgical treatment in patients with aortic valve stenosis and concomitant coronary artery disease: Study-level meta-analysis with reconstructed time-to-event data

Evaluation and management of coronary artery disease in patients undergoing transcatheter aortic valve implantation

A systematic review and meta-analysis of delayed coronary artery access for coronary angiography with or without percutaneous coronary intervention (PCI) in patients who underwent transcatheter aortic valve replacement (TAVR)

Fractional Flow Reserve in Left Main Bifurcation from a Single Fluoroscopic View Versus Computed Tomography

Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement

Transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and cardiogenic shock

Transcatheter aortic valve replacement for bicuspid aortic valve disease: does conventional surgery have a future?

Contemporary outcomes of surgical aortic valve replacement in patients referred for a transcatheter approach

Optimizing Anesthetic Selection in Transcatheter Aortic Valve Replacement: Striking a Delicate Balance between Efficacy and Minimal Intervention

Managing the patient undergoing transcatheter aortic valve replacement with ongoing mitral regurgitation

Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?

The Safety of Concomitant Transcatheter Aortic Valve Replacement and Percutaneous Coronary Intervention

Characterization and Management of Stable Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation

Feasibility and Safety of Post-Transcatheter Aortic Valve Replacement Coronary Revascularization Guided by Stress Cardiac Imaging

Efficacy and safety of TAVR versus SAVR in patients with small aortic annuli: A systematic review and meta-analysis

Treating the patients in the 'grey-zone' with aortic valve disease: a comparison among conventional surgery, sutureless valves and transcatheter aortic valve replacement